@misc{misc, title  = {{P73 Laboratory safety from a 16-week phase III study of dupilumab in patients aged 6 months–5 years with moderate-to-severe atopic dermatitis}},

 url = {{}},

 year = {{2023}},

 month = {{6}},

 author = {{Paller AS and Cork MJ and Wollenberg A and Siegfried EC and Gonzalez ME and Lockshin B and Khokhar FA and Chen Z and Gonzalez T and Simcox E and Prescilla R}},

 note = {{Accessed on 2024/12/22}}}